Page last updated: 2024-08-23

raloxifene hydrochloride and pituitrin

raloxifene hydrochloride has been researched along with pituitrin in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Berkó, A; Cox, DA; László, F; László, FA; Morschl, E; Nemcsik, J; Pávó, I	1

Other Studies

1 other study(ies) available for raloxifene hydrochloride and pituitrin

Article	Year
Raloxifene, an oestrogen-receptor modulator, prevents decreased constitutive nitric oxide and vasoconstriction in ovariectomized rats. European journal of pharmacology, 2000, Dec-20, Volume: 410, Issue:1 Topics: Animals; Blood Pressure; Calcium; Catecholamines; Dose-Response Relationship, Drug; Estrogens; Female; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Ovariectomy; Ovary; Raloxifene Hydrochloride; Rats; Rats, Wistar; Selective Estrogen Receptor Modulators; Vasoconstriction; Vasopressins	2000

Article

Year

Raloxifene, an oestrogen-receptor modulator, prevents decreased constitutive nitric oxide and vasoconstriction in ovariectomized rats.

European journal of pharmacology, 2000, Dec-20, Volume: 410, Issue:1

Topics: Animals; Blood Pressure; Calcium; Catecholamines; Dose-Response Relationship, Drug; Estrogens; Female; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Ovariectomy; Ovary; Raloxifene Hydrochloride; Rats; Rats, Wistar; Selective Estrogen Receptor Modulators; Vasoconstriction; Vasopressins

2000